Yufeng Shang

671 total citations
30 papers, 443 citations indexed

About

Yufeng Shang is a scholar working on Hematology, Molecular Biology and Infectious Diseases. According to data from OpenAlex, Yufeng Shang has authored 30 papers receiving a total of 443 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Hematology, 9 papers in Molecular Biology and 6 papers in Infectious Diseases. Recurrent topics in Yufeng Shang's work include COVID-19 Clinical Research Studies (6 papers), Multiple Myeloma Research and Treatments (5 papers) and SARS-CoV-2 and COVID-19 Research (4 papers). Yufeng Shang is often cited by papers focused on COVID-19 Clinical Research Studies (6 papers), Multiple Myeloma Research and Treatments (5 papers) and SARS-CoV-2 and COVID-19 Research (4 papers). Yufeng Shang collaborates with scholars based in China, United States and Japan. Yufeng Shang's co-authors include Fuling Zhou, Yongchang Wei, Liang Shao, Tao Liu, Xinghuan Wang, Jingfeng Li, Haibo Xu, Zhigang Zhao, Yongxi Zhang and Zhiyong Peng and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Oncogene.

In The Last Decade

Yufeng Shang

28 papers receiving 437 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yufeng Shang China 10 131 130 108 94 53 30 443
Anne‐Marie Langevin United States 12 103 0.8× 70 0.5× 113 1.0× 43 0.5× 64 1.2× 29 518
Kyung D. Moon United States 9 186 1.4× 140 1.1× 97 0.9× 96 1.0× 22 0.4× 11 496
Rebecca Hasseli Germany 10 66 0.5× 84 0.6× 67 0.6× 59 0.6× 19 0.4× 26 341
Lai Xu Canada 10 86 0.7× 115 0.9× 68 0.6× 53 0.6× 40 0.8× 12 369
Cristina Bagacean France 13 147 1.1× 89 0.7× 90 0.8× 35 0.4× 42 0.8× 29 604
Arianna Damiani Italy 13 66 0.5× 133 1.0× 86 0.8× 47 0.5× 10 0.2× 55 633
Chelsea Kotch United States 4 59 0.5× 96 0.7× 131 1.2× 102 1.1× 8 0.2× 13 315
Yibin Zhang China 13 218 1.7× 18 0.1× 98 0.9× 90 1.0× 41 0.8× 54 502
Gerasimos Evangelatos Greece 13 130 1.0× 63 0.5× 74 0.7× 19 0.2× 86 1.6× 37 567
Deepak Atri United States 7 161 1.2× 174 1.3× 118 1.1× 123 1.3× 22 0.4× 13 503

Countries citing papers authored by Yufeng Shang

Since Specialization
Citations

This map shows the geographic impact of Yufeng Shang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yufeng Shang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yufeng Shang more than expected).

Fields of papers citing papers by Yufeng Shang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yufeng Shang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yufeng Shang. The network helps show where Yufeng Shang may publish in the future.

Co-authorship network of co-authors of Yufeng Shang

This figure shows the co-authorship network connecting the top 25 collaborators of Yufeng Shang. A scholar is included among the top collaborators of Yufeng Shang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yufeng Shang. Yufeng Shang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Bo, Pengfei Xu, Joy C. Yang, et al.. (2024). Plexin D1 emerges as a novel target in the development of neural lineage plasticity in treatment-resistant prostate cancer. Oncogene. 43(30). 2325–2337. 3 indexed citations
2.
3.
Shang, Yufeng, Guopeng Chen, Li Liu, et al.. (2024). Clinical and immunological characteristics of high-risk double-hit multiple myeloma. BMC Cancer. 24(1). 1373–1373.
4.
Huang, Shuai, Yufeng Shang, Lan Wang, et al.. (2024). Variations of rumen metagenome and metabolome in dairy cows with different feed intake levels during the postpartum period. SHILAP Revista de lepidopterología. 2. 1 indexed citations
5.
6.
Liu, Xiaoyan, Hui Shen, Yufeng Shang, et al.. (2022). HIV Infection Induces Aberrant Myeloid Lineage Differentiation. Blood. 140(Supplement 1). 11399–11399. 1 indexed citations
7.
8.
Yu, Yalan, Hui Shen, Li Liu, et al.. (2022). Interphase Fluorescence <em>in situ</em> Hybridization of Bone Marrow Smears of Multiple Myeloma. Journal of Visualized Experiments. 1 indexed citations
9.
Xiao, Wei, Linlu Ma, Yufeng Shang, et al.. (2022). Cardiac-Related Lesions in Newly Diagnosed Patients With Acute Leukemia: A Chinese Population-Based Real-World Study. Frontiers in Medicine. 9. 844350–844350. 4 indexed citations
10.
Shang, Yufeng, et al.. (2021). Biological Characteristics of Umbilical Cord Mesenchymal Stem Cells and Its Therapeutic Potential for Hematological Disorders. Frontiers in Cell and Developmental Biology. 9. 570179–570179. 51 indexed citations
11.
Shang, Yufeng, et al.. (2021). Impact of Treatment Regimens on Antibody Response to the SARS-CoV-2 Coronavirus. Frontiers in Immunology. 12. 580147–580147. 1 indexed citations
12.
Jiang, Hongqiang, Yanxia Jin, Yufeng Shang, et al.. (2021). Therapeutic Plateletpheresis in Patients With Thrombocytosis: Gender, Hemoglobin Before Apheresis Significantly Affect Collection Efficiency. Frontiers in Medicine. 8. 762419–762419. 2 indexed citations
13.
Xiao, Wei, Linlu Ma, Yufeng Shang, Yuxin Tan, & Fuling Zhou. (2021). Cardiac-Related Lesions in Newly Diagnosed Patients with Acute Leukemia. Blood. 138(Supplement 1). 3381–3381. 1 indexed citations
14.
Shang, Yufeng, et al.. (2021). Half‐year follow‐up of patients recovering from severe COVID‐19: Analysis of symptoms and their risk factors. Journal of Internal Medicine. 290(2). 444–450. 43 indexed citations
15.
Zhang, Dongdong, Ziyi Luo, Yanxia Jin, et al.. (2020). Azelaic Acid Exerts Antileukemia Effects against Acute Myeloid Leukemia by Regulating the Prdxs/ROS Signaling Pathway. Oxidative Medicine and Cellular Longevity. 2020. 1–16. 17 indexed citations
16.
Shang, Yufeng, Tao Liu, Yongchang Wei, et al.. (2020). Scoring systems for predicting mortality for severe patients with COVID-19. EClinicalMedicine. 24. 100426–100426. 116 indexed citations
17.
Shang, Yufeng & Fuling Zhou. (2019). Current Advances in Immunotherapy for Acute Leukemia: An Overview of Antibody, Chimeric Antigen Receptor, Immune Checkpoint, and Natural Killer. Frontiers in Oncology. 9. 917–917. 20 indexed citations
18.
Jin, Yanxia, Yufeng Shang, Lu Ding, et al.. (2019). <p>A Retrospective Analysis: A Novel Index Predicts Survival and Risk-Stratification for Bone Destruction in 419 Newly Diagnosed Multiple Myelomas</p>. OncoTargets and Therapy. Volume 12. 10587–10596. 3 indexed citations
19.
Xue, Weili, Wei‐Ming Li, Yufeng Shang, et al.. (2018). One method to establish Epstein‐Barr virus‐associated NK/T cell lymphoma mouse models. Journal of Cellular and Molecular Medicine. 23(2). 1509–1516. 4 indexed citations
20.
Shang, Yufeng, Xiaorui Fu, Yu Chang, Yanan Li, & Mingzhi Zhang. (2018). B2 microglobulin is a novel prognostic marker of Angioimmunoblastic T-cell lymphoma. Scientific Reports. 8(1). 12907–12907. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anne‐Marie Langevin Breakdown of academic impact, for papers by Kyung D. Moon Breakdown of academic impact, for papers by Rebecca Hasseli Breakdown of academic impact, for papers by Lai Xu Breakdown of academic impact, for papers by Cristina Bagacean Breakdown of academic impact, for papers by Arianna Damiani Breakdown of academic impact, for papers by Chelsea Kotch Breakdown of academic impact, for papers by Yibin Zhang Breakdown of academic impact, for papers by Gerasimos Evangelatos Breakdown of academic impact, for papers by Deepak Atri
Rankless by CCL
2026